Toxicity Is Not Associated with Age or Comorbidity Score in a Randomised Study of Oral Fludarabine and Cyclophosphamide and IV Rituximab (FCR) As First-Line Therapy of Fit, Elderly Patients with Chronic Lymphocytic Leukemia (CLL)
Stephen P. Mulligan(Royal North Shore Hospital), Bryone J. Kuss(Flinders Medical Centre), Rosemary Harrup(University of Tasmania), Juliana Di Iulio(Peter MacCallum Cancer Centre), Maya Latimer(Georgetown University), Devinder Gill(Princess Alexandra Hospital), William Renwick(The Royal Melbourne Hospital), Mathias Bressel(Peter MacCallum Cancer Centre), Naomi Mackinlay(Royal North Shore Hospital), Melanie Sulda(Flinders Medical Centre), Cecily Forsyth(Gosford Hospital), Leanne Berkahn(Auckland City Hospital), Philip Campbell(Barwon Health), Paul Turner(Imperial College London), Gavin Cull(Sir Charles Gairdner Hospital), David R. Simpson(North Shore Hospital), Giles Best(Flinders University)
Cited by 5
Related Papers
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
World Allergy Organization Anaphylaxis Guidance 2020
|World Allergy Organization Journal|2020|1.1k
International consensus guidelines for the diagnosis and management of food protein–induced enterocolitis syndrome: Executive summary—Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & Immunology
|Journal of Allergy and Clinical Immunology|2017|675